FDA won’t be hurried to create CBD exceptions amid safety concerns, official says

A top official for the U.S. Food and Drug Administration (FDA) said the agency is concerned that developing a legal exception for supplements containing CBD could send the wrong message, both to companies interested in entering the market and consumers. Lowell Schiller, the FDA’s principal associate commissioner for policy who is leading a panel investigating […]

FDA won’t be hurried to create CBD exceptions amid safety concerns, official says is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

* This article was originally published here

Please follow and like us: